Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3408]
News [7772]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
Checkpoint inhibitor therapy benefits advanced bladder cancer patients
Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA
Checkpoint inhibitor therapy benefits advanced bladder cancer patients ( Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA )
7 Jun 2016
Neuroblastoma outcomes improved with second stem cell transplant
Dr Julie Park - Seattle Children's Hospital, Seattle, USA
Neuroblastoma outcomes improved with second stem cell transplant ( Dr Julie Park - Seattle Children's Hospital, Seattle, USA )
6 Jun 2016
Adjuvant docetaxel fails after radical prostatectomy for high risk prostate...
Dr Goran Ahlgren - Lund University, Malmö, Sweden
Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer ( Dr Goran Ahlgren - Lund University, Malmö, Sweden )
6 Jun 2016
Consolidative therapy extends PFS for NSCLC patients
Prof Daniel Richard Gomez - University of Texas MD Anderson Cancer Center...
Consolidative therapy extends PFS for NSCLC patients ( Prof Daniel Richard Gomez - University of Texas MD Anderson Cancer Center, Houston, USA )
6 Jun 2016
Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC
Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA
Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC ( Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA )
6 Jun 2016
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma
Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA
Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )
6 Jun 2016
Ten years of letrozole improves survival and quality of life in early-diagnosed...
Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada
Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )
6 Jun 2016
Daratumumab slows progression in refractory multiple myeloma
Prof Palumbo - University of Turin, Turin, Italy
Daratumumab slows progression in refractory multiple myeloma ( Prof Palumbo - University of Turin, Turin, Italy )
6 Jun 2016
Developments in haematological malignancies
Dr Stephen Nimer - University of Miami, Miami, USA
Developments in haematological malignancies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016
Recent developments in targeted therapies
Dr Stephen Nimer - University of Miami, Miami, USA
Recent developments in targeted therapies ( Dr Stephen Nimer - University of Miami, Miami, USA )
6 Jun 2016
MyPathway guidance of targeted therapy based on molecular profiles
Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA
MyPathway guidance of targeted therapy based on molecular profiles ( Dr John Hainsworth - Sarah Cannon Research Institute, Nashville, USA )
6 Jun 2016
Testing the safety and efficacy of the PD-L1 antibody durvalumab
Dr Christophe Massard - Institut Gustave Roussy, Paris, France
Testing the safety and efficacy of the PD-L1 antibody durvalumab ( Dr Christophe Massard - Institut Gustave Roussy, Paris, France )
6 Jun 2016

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation